HB 273 Delaware House · 151st General Assembly (2021-2022)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO SYNTHETIC CANNABINOIDS.

Summary
This Act updates the synthetic cannabinoids listed on Schedule I of the Uniform Controlled Substances Act by using broader language so that new synthetic cannabinoids created after the enactment of this Act fall within this definition without needing to be specifically listed. This Act requires a greater than majority vote for passage because § 28 of Article IV of the Delaware Constitution requires the affirmative vote of two-thirds of the members elected to each house of the General Assembly to give jurisdiction to inferior courts and possession of a controlled substance is a misdemeanor under § 4763 of Title 16.
Bill status signed all 5 stages cleared
Introduction
Jan 2022
Committee Review
May 2022
House Passage
Apr 2022
Senate Passage
Jun 2022
Signed into Law
Jun 2022
Introduced Jan 6, 2022 Signed Jun 30, 2022
Floor votes · House Apr 7, 2022

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
7
Key actions
5
Committee
2
Jun 30, 2022
Signed into law
Signed by Governor
executive
Jun 14, 2022
Upper · Passed
Passed By Senate. Votes: 19 YES 2 NO
upper
May 18, 2022
Upper · Passed
Reported Out of Committee (Health & Social Services) in Senate with 3 Favorable, 3 On Its Merits
upper
Apr 7, 2022
Introduced
Assigned to Health & Social Services Committee in Senate
upper
Apr 7, 2022
Lower · Passed
Passed By House. Votes: 37 YES 4 ABSENT
lower
Mar 23, 2022
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 10 Favorable
lower
Jan 6, 2022
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
2 primary · 9 co-sponsors

Sponsors